SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Smallpox Drug May Protect Against Common Cold; It Reduced Ability Of Adenovirus To Replicate In Key Organs, Saint Louis University Study
May 21, 2008
 · 
1 min read
Drug Development
Vaccine Triggers Immune Response, Prevents Alzheimer’s In Mice, University of Rochester Study
May 20, 2008
 · 
1 min read
Drug Development
New Drug Reduces One Cause Of Vision Loss, The Scripps Research Institute Study
May 19, 2008
 · 
1 min read
Drug Development
Drug Therapy For PKU Reverses Heart Damage, Johns Hopkins University School of Medicine Study
May 14, 2008
 · 
1 min read
Drug Development
New Immune Treatment May Control AIDS Virus, University of Melbourne Study
May 5, 2008
 · 
1 min read
Drug Development
Australian Scientists Report Weight Loss Breakthrough; Blood Pressure Drug Aid In Weight Loss
April 29, 2008
 · 
1 min read
Drug Development
Spinal Cord Injury Research Hampered By Animal Models, Says New Study
April 28, 2008
 · 
1 min read
Drug Development
Primary Driver Of Stomach Cancer Development Identified, Ludwig Institute For Cancer Research (LICR) Study
April 23, 2008
 · 
1 min read
Drug Development
Pot Plus Alcohol Kills Young Rats’ Brain Cells, Humboldt University, Berlin Study
April 23, 2008
 · 
1 min read
Drug Development
Aida Pharmaceuticals, Inc. Reveals Second Anti-Cancer Drug
April 21, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147
January 8, 2026
 · 
7 min read
Press Releases
Espervita’s EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication
January 7, 2026
 · 
2 min read
Press Releases
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
January 6, 2026
 · 
5 min read
Press Releases
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
January 6, 2026
 · 
10 min read
Press Releases
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
January 5, 2026
 · 
6 min read
Press Releases
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
January 5, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
January 5, 2026
 · 
6 min read
Press Releases
Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology
December 23, 2025
 · 
3 min read
Press Releases
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
December 22, 2025
 · 
3 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
December 18, 2025
 · 
2 min read
Press Releases
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
December 18, 2025
 · 
4 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
 · 
4 min read
Press Releases
Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury
December 16, 2025
 · 
4 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
 · 
6 min read
Press Releases
Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
December 15, 2025
 · 
2 min read
Press Releases
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
December 12, 2025
 · 
5 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
 · 
3 min read
Press Releases
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
December 12, 2025
 · 
3 min read
Press Releases
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
December 12, 2025
 · 
6 min read
Load More